 Tonix Pharmaceuticals Holding Corp NASDAQ: TNXP said in a regulatory filing that plans are underway to construct a commercial-scale manufacturing site to develop and manufacture vaccines, including its experimental COVID-19 shot, TNX-1800. The Montana facility intended to develop and manufacture Tonixs vaccine candidates will be a publicprivate sector collaboration between Ravalli County and Tonix Pharmaceuticals that will bring more high-tech bioscience jobs to the Bitterroot Valley, the company said. 